Jamjoom Pharmaceuticals Factory Company
SAU: 4015.SR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Saudi Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Tarek Youssef Hussein Hosni
- Employees
- 1,079
- Headquarters
- Jeddah, Saudi Arabia
- IPO year
- 2023
- Market cap
- SAR 10.3B
- Website
- https://www.jamjoompharma.com
Loading 4015…
Loading profile data…Frequently asked questions about 4015
What does Jamjoom Pharmaceuticals Factory Company (4015.SR) do?
Established in 1994, Jamjoom Pharmaceuticals Factory Company, headquartered in Jeddah, Saudi Arabia, is a key player in the production and commercialization of medicinal products. The firm serves markets both within the Kingdom of Saudi Arabia and across various international regions. Its extensive product portfolio addresses a wide array of the...
Where does 4015.SR trade?
Jamjoom Pharmaceuticals Factory Company (4015.SR) trades on the Saudi Exchange.
What sector is 4015.SR in?
Jamjoom Pharmaceuticals Factory Company (4015.SR) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jamjoom Pharmaceuticals Factory Company?
Tarek Youssef Hussein Hosni is the chief executive officer of Jamjoom Pharmaceuticals Factory Company (4015.SR).
Where is Jamjoom Pharmaceuticals Factory Company headquartered?
Jamjoom Pharmaceuticals Factory Company is headquartered in Saudi Arabia.
When did 4015.SR go public?
Jamjoom Pharmaceuticals Factory Company (4015.SR) completed its initial public offering in 2023.